503A & 503B Compounders

503B FDA registered outsourcing facilities and 503A pharmacy compounders  provide lifesaving medications to prevent drug shortages and must meet strict compliance and regulation requirements. RCA is the leader in ensuring 503A and 503B facilities meet the highest regulatory and quality standards. Our regulatory experts provide comprehensive cGMP services to ensure companies comply with FDA and State regulations.

Compliance & Quality Support for 503A and 503B Compounders

503A and 503B compounding organizations continue to face increased regulatory oversight, evolving FDA guidance, and growing expectations around sterile operations, documentation practices, and quality systems. Maintaining inspection readiness while managing day-to-day operations can place significant strain on internal teams.

RCA provides specialized consulting support for compounding pharmacies and outsourcing facilities seeking to improve compliance, strengthen quality systems, and reduce operational risk.

Our consultants understand the unique operational realities of compounding environments and deliver practical, inspection-focused solutions designed to support patient safety, business continuity, and sustainable compliance.

Why Compounders Choose RCA

Practical, inspection-focused expertise
Former FDA and compounding specialists
Hands-on remediation support
Flexible consulting engagements
Scalable quality and compliance resources
Deep sterile operations experience

Our Solutions

Click below to learn more about each of our solutions.

Product Development Whether you are developing a new product, updating a legacy device, or responding to a regulatory setback, the challenge is the same: your product must be supported by a complete, defensible design and development framework.Regulatory AffairsWhether you are developing a new product, updating a legacy device, or responding to a regulatory setback, the challenge is the same: your product must be supported by a complete, defensible design and development framework.Quality & ComplianceWhether you’re developing a new product or working through an existing FDA issue, your goal is the same: a seamless path to compliance and ongoing product quality. RCA can provide you with the structure, expertise, and actionable insights required to help you navigate the inspection process and keep your operations running smoothly.Inspection Readiness & EnforcementFrom simple OTCs to advanced sterile and combination products, every company and every facility will face inspection. And what happens in that moment determines everything that follows. We provide the structure, expertise, and actionable insights required to help you navigate the complexed drug approval inspection process or respond to FDA 483 or WL during a remediation process, or respond during remediation, and keep your operations running smoothly.Mergers & AcquisitionsClosing a deal is only the beginning. In life sciences, the real risk and the real value are realized after the transaction. Regulatory gaps, quality system weaknesses, and operational disconnects can quickly erode projected returns if they are not identified and addressed early. What looks like a strong asset on paper can become a costly remediation effort without the right visibility and planning.Outsourcing & Staff AugmentationLife sciences organizations are built to run lean but regulatory and quality demands rarely follow a predictable path. As products move through different stages of development and commercialization, resource needs rise and fall quickly, often faster than internal hiring can accommodate.

Related Content

Podcasts

503 Compounding: Challenges, Compliance & the Road Ahead

In this episode of RCA Radio, host Brandon Miller is joined by RCA experts Anita Michael and Arie Anahory for a deep dive into the evolving world of compounding pharmacies....
Read More

White Papers

How to Transition from 503A to 503B: A Road-Map to Compliance

This white paper presents a detailed roadmap for compounding pharmacies aiming to transition from a 503A patient-specific model to a 503B outsourcing facility. It explores the strategic planning, facility design,...
Read More

Case Studies

Remediation & Resulting Sustainable Compliance

A recently registered 503B Sterile Outsourcing Facility was facing serious enforcement action from the FDA. Under RCA's guidance, the company became one of the first outsourcing facilities to remediate FDA's...
Read More

Begin the Regulatory Compliance Associates Scoping Process Today

Contact Us